Sub-inhibitory Concentrations of Colistin and Imipenem Impact the Expression of Biofilm-associated Genes in Acinetobacter Baumannii

Overview

Journal Arch Microbiol

Specialty Microbiology

Date 2024 Mar 15

PMID 38489041

Authors

J N Bhavya

Sureddi Sai Anugna

Ramya Premanath

Affiliations

Soon will be listed here.

Abstract

Acinetobacter baumannii is an opportunistic pathogen that is responsible for nosocomial infections. Imipenem and colistin are drugs that are commonly used to treat severe infections caused by A. baumannii, such as sepsis, ventilator-associated pneumonia, and bacteremia. However, some strains of A. baumannii have become resistant to these drugs, which is a concern for public health. Biofilms produced by A. baumannii increase their resistance to antibiotics and the cells within the inner layers of biofilm are exposed to sub-inhibitory concentrations (sub-MICs) of antibiotics. There is limited information available regarding how the genes of A. baumannii are linked to biofilm formation when the bacteria are exposed to sub-MICs of imipenem and colistin. Thus, this study's objective was to explore this relationship by examining the genes involved in biofilm formation in A. baumannii when exposed to low levels of imipenem and colistin. The study found that exposing an isolate of A. baumannii to low levels of these drugs caused changes in their drug susceptibility pattern. The relative gene expression profiles of the biofilm-associated genes exhibited a change in their expression profile during short-term and long-term exposure. This study highlights the potential consequences of overuse and misuse of antibiotics, which can help bacteria become resistant to these drugs.

References

Ahsan U, Mushtaq F, Saleem S, Malik A, Sarfaraz H, Shahzad M . Emergence of high colistin resistance in carbapenem resistant in Pakistan and its potential management through immunomodulatory effect of an extract from . Front Pharmacol. 2022; 13:986802. PMC: 9523213. DOI: 10.3389/fphar.2022.986802. View

Al-Bayati M, Samarasinghe S . Biofilm and Gene Expression Characteristics of the Carbapenem-Resistant Enterobacterales, IMP, and NDM-1 Associated with Common Bacterial Infections. Int J Environ Res Public Health. 2022; 19(8). PMC: 9024719. DOI: 10.3390/ijerph19084788. View

Al-Shamiri M, Zhang S, Mi P, Liu Y, Xun M, Yang E . Phenotypic and genotypic characteristics of Acinetobacter baumannii enrolled in the relationship among antibiotic resistance, biofilm formation and motility. Microb Pathog. 2021; 155:104922. DOI: 10.1016/j.micpath.2021.104922. View

Asaad A, Ansari S, Ajlan S, Awad S . Epidemiology of Biofilm Producing Nosocomial Isolates from a Tertiary Care Hospital in Egypt: A Cross-Sectional Study. Infect Drug Resist. 2021; 14:709-717. PMC: 7914062. DOI: 10.2147/IDR.S261939. View

BAUER A, KIRBY W, SHERRIS J, Turck M . Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4):493-6. View

Bogdan M, Drenjancevic D, Harsanji Drenjancevic I, Bedenic B, Zujic Atalic V, Talapko J . In vitro effect of subminimal inhibitory concentrations of antibiotics on the biofilm formation ability of Acinetobacter baumannii clinical isolates. J Chemother. 2017; 30(1):16-24. DOI: 10.1080/1120009X.2017.1378835. View

Boll J, Crofts A, Peters K, Cattoir V, Vollmer W, Davies B . A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii. Proc Natl Acad Sci U S A. 2016; 113(41):E6228-E6237. PMC: 5068286. DOI: 10.1073/pnas.1611594113. View

Bravo Z, Orruno M, Parada C, Kaberdin V, Barcina I, Arana I . The long-term survival of Acinetobacter baumannii ATCC 19606(T) under nutrient-deprived conditions does not require the entry into the viable but non-culturable state. Arch Microbiol. 2016; 198(5):399-407. DOI: 10.1007/s00203-016-1200-1. View

Cavallo I, Oliva A, Pages R, Sivori F, Truglio M, Fabrizio G . in the critically ill: complex infections get complicated. Front Microbiol. 2023; 14:1196774. PMC: 10325864. DOI: 10.3389/fmicb.2023.1196774. View

10.

Chen H, Cao J, Zhou C, Liu H, Zhang X, Zhou T . Biofilm Formation Restrained by Subinhibitory Concentrations of Tigecyclin in Acinetobacter baumannii Is Associated with Downregulation of Efflux Pumps. Chemotherapy. 2016; 62(2):128-133. DOI: 10.1159/000450537. View

11.

Choi A, Slamti L, Avci F, Pier G, Maira-Litran T . The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol. 2009; 191(19):5953-63. PMC: 2747904. DOI: 10.1128/JB.00647-09. View

12.

El-Kazzaz W, Metwally L, Yahia R, Al-Harbi N, El-Taher A, Hetta H . Antibiogram, Prevalence of OXA Carbapenemase Encoding Genes, and RAPD-Genotyping of Multidrug-Resistant Incriminated in Hidden Community-Acquired Infections. Antibiotics (Basel). 2020; 9(9). PMC: 7558960. DOI: 10.3390/antibiotics9090603. View

13.

Eze E, Chenia H, El Zowalaty M . biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. 2018; 11:2277-2299. PMC: 6245380. DOI: 10.2147/IDR.S169894. View

14.

Eze E, El Zowalaty M, Pillay M . Antibiotic resistance and biofilm formation of Acinetobacter baumannii isolated from high-risk effluent water in tertiary hospitals in South Africa. J Glob Antimicrob Resist. 2021; 27:82-90. DOI: 10.1016/j.jgar.2021.08.004. View

15.

Gao R, Mack T, Stock A . Bacterial response regulators: versatile regulatory strategies from common domains. Trends Biochem Sci. 2007; 32(5):225-34. PMC: 3655528. DOI: 10.1016/j.tibs.2007.03.002. View

16.

Gayoso C, Mateos J, Mendez J, Fernandez-Puente P, Rumbo C, Tomas M . Molecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii. J Proteome Res. 2013; 13(2):460-76. DOI: 10.1021/pr400603f. View

17.

Geisinger E, Mortman N, Vargas-Cuebas G, Tai A, Isberg R . A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii. PLoS Pathog. 2018; 14(5):e1007030. PMC: 5967708. DOI: 10.1371/journal.ppat.1007030. View

18.

Henry R, Crane B, Powell D, Deveson Lucas D, Li Z, Aranda J . The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model. J Antimicrob Chemother. 2015; 70(5):1303-13. PMC: 4398468. DOI: 10.1093/jac/dku536. View

19.

Ponmalar I, Swain J, Basu J . response to subinhibitory concentrations of colistin: insights from a study of membrane dynamics and morphology. Biomater Sci. 2022; 10(10):2609-2617. DOI: 10.1039/d2bm00037g. View

20.

Karunasagar A, Maiti B, Shekar M, M S, Karunasagar I . Prevalence of OXA-type carbapenemase genes and genetic heterogeneity in clinical isolates of Acinetobacter spp. from Mangalore, India. Microbiol Immunol. 2011; 55(4):239-46. DOI: 10.1111/j.1348-0421.2011.00313.x. View